Overview

Update
Total Equity Funding
$130.51M in 5 Rounds from 15 Investors
Most Recent Funding
$33M Series C on June 16, 2016
Headquarters:
Cambridge, Massachusetts
Description:
Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.
Founders:
Categories:
Therapeutics, Biotechnology, Medical
Website:
http://www.mersana.com
Social:

Company Details

Update

Mersana Therapeutics employs its biodegradable polymer platform (Fleximer®) to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. They also leverage the versatility of Fleximer through partnerships to overcome the safety, efficacy, and delivery challenges of nucleic acids, biologics, and small molecules in numerous therapeutic areas.

Funding Rounds (7) - $143.01M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2016$33M / Series C6
Mar, 2015$35M / Series B5
Apr, 2014$14.51M / Series A2
Jul, 2012$27M / Series A4
Apr, 2012$10M / Debt Financing0
Feb, 2010$2.5M / Debt Financing0
Nov, 2005$21M / Venture7

Current Team (8)

Update

Offices/Locations (1)

Update
  • Office

    840 Memorial Drive

    Cambridge, Massachusetts 02139

    United States

Past Team (3)

Update

Images (2)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos